Area of research
Endocrine and Autonomic Systems · Molecular Biology
Research interest
Research interests include Medicine, Internal medicine, Placebo, Gastroenterology, Cirrhosis, and Tolerability.
Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia
Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease
Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo
Emricasan (IDN‐6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
The Clinical Approach to the Detection of Lipodystrophy an Aace Consensus Statement